SNCA and Parkinson disease: The pathology of Parkinson disease (PD), the second most common neurodegenerative disease, is characterized by the formation of α-synuclein aggregates in the form of Lewy bodies (LB) and the selective loss of dopaminergic (DA) neurons in the substantia nigra [1].